0001179110-16-026305.txt : 20160609 0001179110-16-026305.hdr.sgml : 20160609 20160609163002 ACCESSION NUMBER: 0001179110-16-026305 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160608 FILED AS OF DATE: 20160609 DATE AS OF CHANGE: 20160609 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celldex Therapeutics, Inc. CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 BUSINESS PHONE: 908-200-7500 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD STREET 2: SUITE 220 CITY: HAMPTON STATE: NJ ZIP: 08827 FORMER COMPANY: FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19980828 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CATLIN AVERY W CENTRAL INDEX KEY: 0001255348 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 161706310 MAIL ADDRESS: STREET 1: 241 CENTRAL STREET CITY: HINGHAM STATE: MA ZIP: 02043 4 1 edgar.xml FORM 4 - X0306 4 2016-06-08 0 0000744218 Celldex Therapeutics, Inc. CLDX 0001255348 CATLIN AVERY W C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD HAMPTON NJ 08827 0 1 0 0 Sr. VP & CFO Incentive Stock Option 4.72 2016-06-08 4 A 0 135000 0 A 2017-06-08 2026-06-08 Common Stock 135000 135000 D 25% vest on June 8, 2017 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters. /s/ Anthony S. Marucci, attorney in fact for Avery W. Catlin 2016-06-09